MA31867B1 - Agonistes nouveaux des recepteurs de glucocorticoides - Google Patents
Agonistes nouveaux des recepteurs de glucocorticoidesInfo
- Publication number
- MA31867B1 MA31867B1 MA32873A MA32873A MA31867B1 MA 31867 B1 MA31867 B1 MA 31867B1 MA 32873 A MA32873 A MA 32873A MA 32873 A MA32873 A MA 32873A MA 31867 B1 MA31867 B1 MA 31867B1
- Authority
- MA
- Morocco
- Prior art keywords
- glucocorticoid receptors
- disorders
- new agonist
- new
- agonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRÉSENTE INVENTION CONCERNE DE NOUVEAUX AGONISTES DES RÉCEPTEURS DES GLUCOCORTICOÏDES DE FORMULE (I) ET DES PROCÉDÉS ET DES INTERMÉDIAIRES POUR LEUR PRÉPARATION. LA PRÉSENTE INVENTION CONCERNE ÉGALEMENT DES COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSÉS, LEUR COMBINAISON AVEC UN OU PLUSIEURS AUTRES AGENTS THÉRAPEUTIQUES AINSI QUE LEUR UTILISATION POUR LE TRAITEMENT D'UN CERTAIN NOMBRE DE MALADIES, TROUBLES ET AFFECTIONS INFLAMMATOIRES ET ALLERGIQUES.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99135407P | 2007-11-30 | 2007-11-30 | |
US5724108P | 2008-05-30 | 2008-05-30 | |
US7955508P | 2008-07-10 | 2008-07-10 | |
PCT/IB2008/054801 WO2009069032A2 (fr) | 2007-11-30 | 2008-11-17 | Nouveaux agonistes des récepteurs des glucocorticoïdes |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31867B1 true MA31867B1 (fr) | 2010-11-01 |
Family
ID=40427125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32873A MA31867B1 (fr) | 2007-11-30 | 2010-05-28 | Agonistes nouveaux des recepteurs de glucocorticoides |
Country Status (33)
Country | Link |
---|---|
US (2) | US8822439B2 (fr) |
EP (1) | EP2225256B1 (fr) |
JP (1) | JP4686650B2 (fr) |
KR (1) | KR101295998B1 (fr) |
CN (1) | CN101878221B (fr) |
AP (1) | AP2010005267A0 (fr) |
AR (1) | AR069490A1 (fr) |
AU (1) | AU2008331187B2 (fr) |
BR (1) | BRPI0820447A2 (fr) |
CA (1) | CA2706180C (fr) |
CL (1) | CL2008003549A1 (fr) |
CO (1) | CO6280401A2 (fr) |
CR (1) | CR11393A (fr) |
DK (1) | DK2225256T3 (fr) |
DO (1) | DOP2010000161A (fr) |
EA (1) | EA201070535A1 (fr) |
EC (1) | ECSP10010209A (fr) |
ES (1) | ES2399945T3 (fr) |
GT (1) | GT201000153A (fr) |
HK (1) | HK1144821A1 (fr) |
IL (1) | IL205356A0 (fr) |
MA (1) | MA31867B1 (fr) |
MX (1) | MX2010005861A (fr) |
NI (1) | NI201000090A (fr) |
NZ (1) | NZ585434A (fr) |
PA (1) | PA8805801A1 (fr) |
PE (1) | PE20091072A1 (fr) |
SV (1) | SV2010003580A (fr) |
TN (1) | TN2010000230A1 (fr) |
TW (1) | TW200930378A (fr) |
UY (1) | UY31496A1 (fr) |
WO (1) | WO2009069032A2 (fr) |
ZA (1) | ZA201003439B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2524057B1 (fr) * | 2010-01-15 | 2016-03-30 | Rigel Pharmaceuticals, Inc. | Essai de criblage utilisant dex et gdf8 |
TW201139369A (en) | 2010-02-05 | 2011-11-16 | Chiesi Farma Spa | Pyrrolidine derivatives |
CN103391945B (zh) * | 2011-03-15 | 2016-11-09 | 奇斯药制品公司 | 异噁唑烷衍生物 |
WO2012123493A2 (fr) | 2011-03-15 | 2012-09-20 | Chiesi Farmaceutici S.P.A. | Dérivés d'isoxazolidine |
FR2984325A1 (fr) * | 2011-12-14 | 2013-06-21 | Sanofi Sa | Derives de pyrazolopyridine, leur procede de preparation et leur application en therapeutique |
TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
WO2014094357A1 (fr) | 2012-12-21 | 2014-06-26 | Abbvie Inc. | Modulateurs hétérocycliques des récepteurs nucléaires aux hormones |
CA2906029C (fr) * | 2013-03-15 | 2017-09-05 | Aprecia Pharmaceuticals Company | Forme pharmaceutique a dispersion rapide contenant du levetiracetam |
US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
EP3244893A4 (fr) | 2015-02-18 | 2019-01-09 | Parion Sciences, Inc. | Bloqueurs de canaux sodiques pour le traitement de troubles de la peau |
PL3464318T3 (pl) * | 2016-06-02 | 2021-11-08 | Abbvie Inc. | Agonista receptora glukokortykoidowego i jego immunokoniugaty |
SG10202110259QA (en) | 2017-10-05 | 2021-10-28 | Fulcrum Therapeutics Inc | Use of p38 inhibitors to reduce expression of dux4 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
US10772970B2 (en) * | 2017-12-01 | 2020-09-15 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
CA3081559A1 (fr) * | 2017-12-01 | 2019-06-06 | Abbvie Inc. | Conjugues medicament-anticorps anti-cd40 |
WO2019180150A1 (fr) | 2018-03-22 | 2019-09-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés de modulation de l'activité des cellules lymphoïdes innées, conjugués anticorps-médicaments et leurs utilisations en thérapie |
CN109734763A (zh) * | 2019-01-20 | 2019-05-10 | 湖南科瑞生物制药股份有限公司 | 一种16a-羟基醋酸***龙产品的制备方法 |
CN109575097A (zh) * | 2019-01-20 | 2019-04-05 | 湖南科瑞生物制药股份有限公司 | 一种16a-羟基***龙产品的新的制备方法 |
CN109651474A (zh) * | 2019-01-20 | 2019-04-19 | 湖南科瑞生物制药股份有限公司 | 一种16a-羟基***龙的新的制备方法 |
CN109575095A (zh) * | 2019-01-20 | 2019-04-05 | 湖南科瑞生物制药股份有限公司 | 一种16a-羟基醋酸***龙的制备方法 |
TW202304462A (zh) | 2021-03-23 | 2023-02-01 | 美商美國禮來大藥廠 | 糖皮質素受體激動劑 |
AR125079A1 (es) | 2021-03-23 | 2023-06-07 | Lilly Co Eli | Agonistas de receptores de glucocorticoides sustituidos con carboxi |
EP4365183A1 (fr) * | 2021-06-24 | 2024-05-08 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Composé stéroïde, composition pharmaceutique et utilisation associées |
WO2023245106A1 (fr) * | 2022-06-16 | 2023-12-21 | Abbvie Biotherapeutics Inc. | Conjugués médicament-anticorps anti-cd19 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3197469A (en) * | 1958-08-06 | 1965-07-27 | Pharmaceutical Res Products In | 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor |
US8232304B2 (en) | 2002-10-24 | 2012-07-31 | G & R Pharmaceuticals, Llc | Antifungal formulations |
WO2005044759A2 (fr) * | 2003-08-14 | 2005-05-19 | Sun Pharmaceutical Industries Limited | Acetalisation pour preparation de composes steroides |
WO2005028495A1 (fr) * | 2003-09-24 | 2005-03-31 | Glaxo Group Limited | Glucocorticoïdes anti-inflammatoires |
GB0402797D0 (en) | 2004-02-09 | 2004-03-10 | Novartis Ag | Organic compounds |
US20050227927A1 (en) | 2004-03-31 | 2005-10-13 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
-
2008
- 2008-11-17 DK DK08854982.9T patent/DK2225256T3/da active
- 2008-11-17 WO PCT/IB2008/054801 patent/WO2009069032A2/fr active Application Filing
- 2008-11-17 JP JP2010535483A patent/JP4686650B2/ja not_active Expired - Fee Related
- 2008-11-17 AP AP2010005267A patent/AP2010005267A0/en unknown
- 2008-11-17 ES ES08854982T patent/ES2399945T3/es active Active
- 2008-11-17 CN CN200880118275.8A patent/CN101878221B/zh not_active Expired - Fee Related
- 2008-11-17 AU AU2008331187A patent/AU2008331187B2/en not_active Ceased
- 2008-11-17 CA CA2706180A patent/CA2706180C/fr not_active Expired - Fee Related
- 2008-11-17 KR KR1020107011610A patent/KR101295998B1/ko not_active IP Right Cessation
- 2008-11-17 MX MX2010005861A patent/MX2010005861A/es active IP Right Grant
- 2008-11-17 EA EA201070535A patent/EA201070535A1/ru unknown
- 2008-11-17 NZ NZ585434A patent/NZ585434A/en not_active IP Right Cessation
- 2008-11-17 BR BRPI0820447-0A patent/BRPI0820447A2/pt not_active IP Right Cessation
- 2008-11-17 EP EP08854982A patent/EP2225256B1/fr active Active
- 2008-11-24 US US12/276,925 patent/US8822439B2/en not_active Expired - Fee Related
- 2008-11-27 PA PA20088805801A patent/PA8805801A1/es unknown
- 2008-11-28 CL CL2008003549A patent/CL2008003549A1/es unknown
- 2008-11-28 AR ARP080105201A patent/AR069490A1/es not_active Application Discontinuation
- 2008-11-28 UY UY31496A patent/UY31496A1/es not_active Application Discontinuation
- 2008-11-28 PE PE2008001996A patent/PE20091072A1/es not_active Application Discontinuation
- 2008-11-28 TW TW097146518A patent/TW200930378A/zh unknown
-
2010
- 2010-04-26 IL IL205356A patent/IL205356A0/en unknown
- 2010-04-26 CR CR11393A patent/CR11393A/es not_active Application Discontinuation
- 2010-05-14 ZA ZA2010/03439A patent/ZA201003439B/en unknown
- 2010-05-21 TN TN2010000230A patent/TN2010000230A1/fr unknown
- 2010-05-24 GT GT201000153A patent/GT201000153A/es unknown
- 2010-05-25 NI NI201000090A patent/NI201000090A/es unknown
- 2010-05-26 CO CO10063356A patent/CO6280401A2/es not_active Application Discontinuation
- 2010-05-28 SV SV2010003580A patent/SV2010003580A/es not_active Application Discontinuation
- 2010-05-28 DO DO2010000161A patent/DOP2010000161A/es unknown
- 2010-05-28 MA MA32873A patent/MA31867B1/fr unknown
- 2010-05-28 EC EC2010010209A patent/ECSP10010209A/es unknown
- 2010-12-09 HK HK10111448.3A patent/HK1144821A1/xx not_active IP Right Cessation
-
2014
- 2014-07-23 US US14/338,434 patent/US20140336160A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31867B1 (fr) | Agonistes nouveaux des recepteurs de glucocorticoides | |
MA30232B1 (fr) | Inhibiteurs de kinase bases sur l'hydantoine | |
MA30539B1 (fr) | Derives de piperazinyle utiles dans le traitement de maladies induites par le recepteur gpr38. | |
MA33920B1 (fr) | Modulateurs allosteriques positifs du recepteur m1 a base de quinolinamide | |
MA34655B1 (fr) | Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse | |
MA28435B1 (fr) | Composes d'indazole-carboxamide en tant qu'agonistes de recepteur 5-ht4 | |
MA33053B1 (fr) | Inhibiteurs de la poly(adp-ribose) polymerase (parp) | |
MA33467B1 (fr) | Promédicaments comprenant un conjugué insuline-lieur | |
MA33538B1 (fr) | Nouveaux antagonistes pyrimidine et triazine de l'hepcidine | |
MA32627B1 (fr) | Derive d'amides heteroaryliques et leur utilisation comme activateurs de glucokinase | |
MA32798B1 (fr) | Acides naphtylacétiques | |
MA33604B1 (fr) | Composés et compositions en tant qu'inhibiteurs de protéine kinase | |
MA30900B1 (fr) | Anticorps d'agonistes anti-notch3 et leur utilisation dans le traitement de maladies liées à notch3 | |
MA31283B1 (fr) | Produits dérivés de 2,3-dihydroimidazo[1,2-c]quinazoline substitués, utiles pour le traitement de troubles hyperlifératifs et de maladies associées à une angiogénèse | |
MA31949B1 (fr) | Dérivés d'aminotriazole comme agonistes d'alx | |
MA31311B1 (fr) | Dérivés d'indazole substitués par oxadiazole, destinés à être utilisés comme agonistes de la sphingosine 1-phosphate (s1p) | |
MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
MA30333B1 (fr) | Aminotetrahydropyranes utiles en tant qu'inhibiteurs de la dipeptidyle peptidase-iv pour le traitement ou la prevention du diabete. | |
MA30906B1 (fr) | Composes et compositions en tant quinhibiteurs des proteines kinases | |
MA31764B1 (fr) | Composés et compositions en tant que modulateurs de l'activité de gpr119 | |
MA30999B1 (fr) | Composés. | |
TN2014000420A1 (fr) | Derives d'indole et d'indazole qui activent la mpk | |
MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
MA35576B1 (fr) | Nouveaux composés | |
MA30514B1 (fr) | Nouveaux composes. |